ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0703

Trends and Disparities in Systemic Sclerosis-related Mortality Rates in the United States from 1999 to 2023

Nicolas Barnechea Alvarado1, Khadija Mohib1, Rameez Qasim2 and Muhammad Ali3, 1Kirk Kerkorian School of Medicine at UNLV, Las Vegas, NV, 2Allama Iqbal Medical College Lahore, Lahore, Pakistan, 3Dow International Medical College, Karachi, Sindh, Pakistan

Meeting: ACR Convergence 2025

Keywords: Demographics, Mortality, Systemic sclerosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 26, 2025

Title: (0671–0710) Systemic Sclerosis & Related Disorders – Clinical Poster I

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Systemic sclerosis is one of the most fatal rheumatologic diseases, with significantly higher mortality rates compared to the general population, likely due to its fibrotic nature and consequential effects on the vasculature system. Although previous observational population-based studies looked into the mortality rates of this disorder, more recent research beyond 2020 is limited, especially analyses stratified by demographic and regional distributions in the United States.

Methods: Datasets from the CDC WONDER Multiple Cause-of-Death public use records from 1999 to 2023 were used to analyze deaths in adults ≥25 years old assigning ICD-10 codes (M34 series) to systemic sclerosis by year and place of death, as well as by demographic (sex, age group, race) and regional (state, census region, rural-urban) stratifications. Age-adjusted mortality rates (AAMR) were calculated per 1,000,000 with 95% confidence intervals by standardizing crude mortality rates (CMR). Annual percent change (APC) and average annual percent change (AAPC) were evaluated using Joinpoint regression software.

Results: 44,407 deaths occurred from 1999 to 2023, mostly in medical facilities (57.3%). AAMR declined from 10.8 to 6.3 in 2018, followed by stability until 5.8 in 2023 (AAPC: -2.4; 95%CI: -2.8 to -2.2). Women had a higher average AAMR compared to men, along with a lower rate of decrease (AAPC women: -2.3; 95%CI: 2.6 to -2.0, men: -2.6; 95%CI: -3.4 to -2.1). Adults ≥65 years old had the highest average AAMR along with the lowest rate of decrease amongst the age groups (AAPC ≥65 years old: -2.0; 95%CI: -2.4 to -1.6, 45-65 years old: -3.3: 95%CI: -3.6 to -3.0, 25-44 years old: -3.2; 95%CI: -3.9 to -2.6). NH Black/African Americans had the highest average AAMR, but had had the highest rate of decrease (AAPC NH Black/African American: -3.1; 95%CI: -3.5 to -2.7, NH White: -2.4; 95%CI -2.9 to -2.1, NH Asian/Pacific Islander: -2.0; 95%CI: -2.7 to -1.3, Hispanic/Latino: -2.3; 95%CI -3.5 to -1.2). Regionally, the Midwest had the highest average AAMR, though the South had the highest rate of decrease (AAPC South: -2.9; 95%CI: -3.4 to -2.5, West: -2.4; 95%CI: -2.9 to -2.0, Midwest: -2.3; 95%CI: -2.6 to -2.0, Northeast: -1.9; 95%CI: -2.4 to -1.6). From 1999 to 2020, AAMR extended from 4.8 in Nevada to 13.6 in South Dakota. From 2021 to 2023, AAMR extended from 3.3 in Alabama to 9.9 in Montana. From 1999-2020, urban areas had higher average AAMR, with a higher rate of decrease (AAPC urban: -2.9; 95%CI: -3.1 to -2.7, rural: -2.5; 95%CI: -2.9 to -2.0).

Conclusion: Whilst systemic sclerosis-related mortality rates in adults declined from 1999 to 2023, disparities amid demographic and regional stratifications were observed; this highlights the need to select prevention and assistance programs for at-risk communities to improve survival outcomes

Supporting image 1

Supporting image 2

Supporting image 3


Disclosures: N. Barnechea Alvarado: None; K. Mohib: None; R. Qasim: None; M. Ali: None.

To cite this abstract in AMA style:

Barnechea Alvarado N, Mohib K, Qasim R, Ali M. Trends and Disparities in Systemic Sclerosis-related Mortality Rates in the United States from 1999 to 2023 [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/trends-and-disparities-in-systemic-sclerosis-related-mortality-rates-in-the-united-states-from-1999-to-2023/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/trends-and-disparities-in-systemic-sclerosis-related-mortality-rates-in-the-united-states-from-1999-to-2023/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology